[HTML][HTML] Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor?

F Babaha, N Rezaei - The American journal of the medical …, 2020 - ncbi.nlm.nih.gov
The novel coronavirus disease 19 (COVID-19) is an acute infectious respiratory disorder that
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …

Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review

BM Liu, HR Hill - Journal of Interferon & Cytokine Research, 2020 - liebertpub.com
Coronavirus disease 2019 (COVID-19) has spread rapidly and become a pandemic.
Caused by a novel human coronavirus called severe acute respiratory syndrome …

COVID‐19 in a child with primary antibody deficiency

H Ahanchian, N Moazzen, M Sezavar… - Clinical Case …, 2021 - Wiley Online Library
Although presentation of COVID‐19 in patients with immunodeficiency could be mild, it
should not be missed, while early diagnosis and appropriate treatment can survive infected …

[HTML][HTML] COVID-19 in patients with primary immunodeficiency

S Esenboga, M Ocak, A Akarsu, HN Bildik… - Journal of clinical …, 2021 - Springer
Method We retrospectively analyzed PID patients in our center, Hacettepe University,
Department of Pediatric Immunology, who had SARS-CoV2 PCR positivity in …

[HTML][HTML] Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel

N Marcus, S Frizinsky, D Hagin, A Ovadia… - Frontiers in …, 2021 - frontiersin.org
In the last few months the world has witnessed a global pandemic due to severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease …

[HTML][HTML] COVID-19: developing from an outbreak to a pandemic

S Hanaei, N Rezaei - Archives of medical research, 2020 - ncbi.nlm.nih.gov
In late 2019, there were first reports of an outbreak of unknown-caused pneumonia from
Wuhan, Hubei province, China. After a week of investigations, the novel coronavirus, COVID …

COVID-19 and non-communicable diseases

R Pal, SK Bhadada - Postgraduate Medical Journal, 2020 - academic.oup.com
Since December 2019, a novel coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has scourged the world, resulting in the …

COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review

E Drzymalla, RF Green, M Knuth, MJ Khoury… - Clinical …, 2022 - Elsevier
A better understanding of COVID-19 in people with primary immunodeficiency (PI), rare
inherited defects in the immune system, is important for protecting this population, especially …

[HTML][HTML] COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: a scoping review

JM Jones, AJ Faruqi, JK Sullivan… - Pathogens and …, 2021 - ncbi.nlm.nih.gov
Background: The role of humoral immunity has been well established in reducing infection
risk and facilitating viral clearance in patients with COVID-19. However, the relationship …

COVID‐19 in HIV‐positive patients: a systematic review of case reports and case series

M Heidary, A Asadi, N Noorbakhsh… - Journal of Clinical …, 2022 - Wiley Online Library
Abstract Introduction Coronavirus disease 2019 (COVID‐19) and acquired immune
deficiency syndrome (AIDS) are two viral diseases for which there are currently no definitive …